Vinícius Dantas Alves

Associate Vice President & Global Brand Lead ASMD Sanofi

Pharma Launch Excellence Summit Conference Day 1: Wednesday September 30

1:30 PM Presentation / Case Study: Building the Market Before Building the Brand: Launching Xenpozyme® as a First-and-Only Rare Disease Therapy

Launching a first-and-only therapy in ultra-rare disease requires more than a strong product profile. Drawing on Vinicius' experience working on Sanofi's global launch of Xenpozyme® (olipudase alfa) for ASMD, Sanofi's best-performing launch since 2015 and the fastest-growing product among analogues, this session will explore how to build ecosystem readiness, own the disease space, and accelerate patient access globally. Attend to delve into:

Connecting development, clinical readouts and access strategy before launch
Building diagnostic, physician and patient community readiness in ASMD
Moving beyond product positioning to shape the broader disease ecosystem
Navigating global access challenges for high-cost rare disease innovation

Check out the incredible speaker line-up to see who will be joining Vinícius.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk